{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:35:57Z","timestamp":1794972957689,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R01MH114967"],"award-info":[{"award-number":["R01MH114967"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Child Adolesc Psychiatry Ment Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressants in pregnancy. Animal and some clinical studies have suggested potential increases in depression and anxiety following prenatal SSRI exposure, but the extent to which these are driven by the medication remains unclear. We used Danish population data to test associations between maternal SSRI use during pregnancy and children outcomes up to age 22.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We prospectively followed 1,094,202 single-birth Danish children born 1997\u20132015. The primary exposure was \u2265\u20091 SSRI prescription filled during pregnancy; the primary outcome, first diagnosis of a depressive, anxiety, or adjustment disorder, or redeemed prescription for an antidepressant medication. We used propensity score weights to adjust potential confounders, and incorporated data from the Danish National Birth Cohort (1997\u20132003) to further quantify potential residual confounding by subclinical factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The final dataset included 15,651 exposed and 896,818 unexposed, children. After adjustments, SSRI-exposed had higher rates of the primary outcome than those of mothers who either did not use an SSRI (HR\u2009=\u20091.55 [95%CI:1.44,1.67] or discontinued the SSRI use\u2009\u2265\u20093 months prior to conception (HR\u2009=\u20091.23 [1.13,1.34]). Age of onset was earlier among exposed (9 [IQR:7\u201313] years) versus unexposed (12 [IQR:12\u201317] years) children (p\u2009&lt;\u20090.01). Paternal SSRI use in the absence of maternal use during the index pregnancy (HR\u2009=\u20091.46 [1.35,1.58]) and maternal SSRI use only after pregnancy (HR\u2009=\u20091.42 [1.35,1.49]) were each also associated with these outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>While SSRI exposure was associated with increased risk in the children, this risk may be driven at least partly by underlying severity of maternal illness or other confounding factors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13034-023-00624-9","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T15:02:49Z","timestamp":1686927769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study"],"prefix":"10.1186","volume":"17","author":[{"given":"Mette","family":"Bliddal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Wesselhoeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Strandberg-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin T.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna M.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"Gingrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardesheer","family":"Talati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"6","key":"624_CR1","first-page":"365","volume":"100","author":"J Mills","year":"2019","unstructured":"Mills J, Day B. Interventions to prevent Perinatal Depression. Am Fam Physician. 2019;100(6):365\u20136.","journal-title":"Am Fam Physician"},{"issue":"7","key":"624_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4088\/JCP.11f07206","volume":"72","author":"MP Freeman","year":"2011","unstructured":"Freeman MP. Antidepressant medication treatment during pregnancy: prevalence of use, clinical implications, and alternatives. J Clin Psychiatry. 2011;72(7):977\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"624_CR3","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1007\/s10995-013-1419-2","volume":"18","author":"AV Margulis","year":"2014","unstructured":"Margulis AV, Kang EM, Hammad TA. Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort. Matern Child Health J. 2014;18(7):1742\u201352.","journal-title":"Matern Child Health J"},{"issue":"4","key":"624_CR4","doi-asserted-by":"publisher","first-page":"e63034","DOI":"10.1371\/journal.pone.0063034","volume":"8","author":"E Jimenez-Solem","year":"2013","unstructured":"Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Andersen NL, Torp-Pedersen C, et al. Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study. PLoS ONE. 2013;8(4):e63034.","journal-title":"PLoS ONE"},{"issue":"2","key":"624_CR5","doi-asserted-by":"publisher","first-page":"194e1","DOI":"10.1016\/j.ajog.2007.07.036","volume":"198","author":"SE Andrade","year":"2008","unstructured":"Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198(2):194e1\u20135.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"624_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","volume":"160","author":"V Hendrick","year":"2003","unstructured":"Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry. 2003;160(5):993\u20136.","journal-title":"Am J Psychiatry"},{"key":"624_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuroscience.2016.02.037","volume":"342","author":"S Brummelte","year":"2017","unstructured":"Brummelte S, Mc Glanaghy E, Bonnin A, Oberlander TF. Developmental changes in serotonin signaling: implications for early brain function, behavior and adaptation. Neuroscience. 2017;342:212\u201331.","journal-title":"Neuroscience"},{"issue":"6","key":"624_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/clpt.2009.201","volume":"86","author":"TF Oberlander","year":"2009","unstructured":"Oberlander TF, Gingrich JA, Ansorge MS. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 2009;86(6):672\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"26","key":"624_CR9","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1056\/NEJMoa066584","volume":"356","author":"S Alwan","year":"2007","unstructured":"Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM, National Birth Defects Prevention S. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007;356(26):2684\u201392.","journal-title":"N Engl J Med"},{"issue":"6","key":"624_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ajog.2015.01.034","volume":"212","author":"A Berard","year":"2015","unstructured":"Berard A, Zhao JP, Sheehy O. Sertraline use during pregnancy and the risk of major malformations. Am J Obstet Gynecol. 2015;212(6):795. e1- e12.","journal-title":"Am J Obstet Gynecol"},{"issue":"14","key":"624_CR11","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","volume":"335","author":"CD Chambers","year":"1996","unstructured":"Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335(14):1010\u20135.","journal-title":"N Engl J Med"},{"issue":"1","key":"624_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/AOG.0b013e318220edcc","volume":"118","author":"H Malm","year":"2011","unstructured":"Malm H, Artama M, Gissler M, Ritvanen A. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol. 2011;118(1):111\u201320.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"624_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1523\/JNEUROSCI.3973-07.2008","volume":"28","author":"MS Ansorge","year":"2008","unstructured":"Ansorge MS, Morelli E, Gingrich JA. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci. 2008;28(1):199\u2013207.","journal-title":"J Neurosci"},{"issue":"5697","key":"624_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1126\/science.1101678","volume":"306","author":"MS Ansorge","year":"2004","unstructured":"Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science. 2004;306(5697):879\u201381.","journal-title":"Science"},{"issue":"5","key":"624_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaac.2016.02.013","volume":"55","author":"H Malm","year":"2016","unstructured":"Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomaki S, McKeague IW, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring Psychiatric Disorders: a National Register-Based study. J Am Acad Child Adolesc Psychiatry. 2016;55(5):359\u201366.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"624_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.reprotox.2020.11.013","volume":"99","author":"SM Hutchison","year":"2021","unstructured":"Hutchison SM, Masse LC, Pawluski JL, Oberlander TF. Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: a review of findings in humans and rodent models. Reprod Toxicol. 2021;99:80\u201395.","journal-title":"Reprod Toxicol"},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"j3668","DOI":"10.1136\/bmj.j3668","volume":"358","author":"X Liu","year":"2017","unstructured":"Liu X, Agerbo E, Ingstrup KG, Musliner K, Meltzer-Brody S, Bergink V, et al. Antidepressant use during pregnancy and psychiatric disorders in offspring: danish nationwide register based cohort study. BMJ (Clinical research ed). 2017;358:j3668.","journal-title":"BMJ (Clinical research ed)"},{"key":"624_CR18","doi-asserted-by":"crossref","unstructured":"Rommel AS, Bergink V, Liu X, Munk-Olsen T, Molenaar NM. Long-Term Effects of Intrauterine exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes: a systematic review. J Clin Psychiatry. 2020;81(3).","DOI":"10.4088\/JCP.19r12965"},{"issue":"8","key":"624_CR19","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41386-021-01005-6","volume":"46","author":"AS Rommel","year":"2021","unstructured":"Rommel AS, Momen NC, Molenaar NM, Liu X, Munk-Olsen T, Bergink V. Long-term prenatal effects of antidepressant use on the risk of affective disorders in the offspring: a register-based cohort study. Neuropsychopharmacology. 2021;46(8):1518\u201325.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"624_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/14034948010290040201","volume":"29","author":"J Olsen","year":"2001","unstructured":"Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, et al. The danish National Birth cohort\u2013its background, structure and aim. Scand J Public Health. 2001;29(4):300\u20137.","journal-title":"Scand J Public Health"},{"issue":"8","key":"624_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, Sorensen HT. The danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541\u20139.","journal-title":"Eur J Epidemiol"},{"key":"624_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"624_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","volume":"33","author":"M Bliddal","year":"2018","unstructured":"Bliddal M, Broe A, Pottegard A, Olsen J, Langhoff-Roos J. The danish Medical Birth Register. Eur J Epidemiol. 2018;33(1):27\u201336.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"624_CR24","first-page":"798","volume":"46","author":"A Pottegard","year":"2017","unstructured":"Pottegard A, Schmidt SAJ, Wallach-Kildemoes H, Sorensen HT, Hallas J, Schmidt M. Data Resource Profile: the danish national prescription Registry. Int J Epidemiol. 2017;46(3):798\u2013f.","journal-title":"Int J Epidemiol"},{"issue":"7 Suppl","key":"624_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1403494811405098","volume":"39","author":"M Baadsgaard","year":"2011","unstructured":"Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7 Suppl):103\u20135.","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"624_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1403494810394715","volume":"39","author":"VM Jensen","year":"2011","unstructured":"Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7 Suppl):91\u20134.","journal-title":"Scand J Public Health"},{"issue":"6","key":"624_CR27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/joim.12197","volume":"275","author":"T Sturmer","year":"2014","unstructured":"Sturmer T, Wyss R, Glynn RJ, Brookhart MA. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med. 2014;275(6):570\u201380.","journal-title":"J Intern Med"},{"issue":"7","key":"624_CR28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/aje\/kwq198","volume":"172","author":"T Sturmer","year":"2010","unstructured":"Sturmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2013a simulation study. Am J Epidemiol. 2010;172(7):843\u201354.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"624_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","volume":"6","author":"MA Brookhart","year":"2013","unstructured":"Brookhart MA, Wyss R, Layton JB, Sturmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes. 2013;6(5):604\u201311.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"Suppl 2","key":"624_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/pds.3263","volume":"21","author":"JA Rassen","year":"2012","unstructured":"Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 2):69\u201380.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"624_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1176\/ajp.2006.163.6.1001","volume":"163","author":"MM Weissman","year":"2006","unstructured":"Weissman MM, Wickramaratne P, Nomura Y, Warner V, Pilowsky D, Verdeli H. Offspring of depressed parents: 20 years later. Am J Psychiatry. 2006;163(6):1001\u20138.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"624_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/bdra.23032","volume":"94","author":"GE Hanley","year":"2012","unstructured":"Hanley GE, Oberlander TF. Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a \u201csocial teratogen\u201d or moderator of developmental risk? Birth Defects Res A Clin Mol Teratol. 2012;94(8):651\u20139.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"624_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1001\/archpedi.161.1.22","volume":"161","author":"TF Oberlander","year":"2007","unstructured":"Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau RE. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med. 2007;161(1):22\u20139.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"624_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1176\/ajp.2006.163.6.1026","volume":"163","author":"S Misri","year":"2006","unstructured":"Misri S, Reebye P, Kendrick K, Carter D, Ryan D, Grunau RE, et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry. 2006;163(6):1026\u201332.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"624_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coph.2006.11.006","volume":"7","author":"MS Ansorge","year":"2007","unstructured":"Ansorge MS, Hen R, Gingrich JA. Neurodevelopmental origins of depressive disorders. Curr Opin Pharmacol. 2007;7(1):8\u201317.","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"624_CR36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jama.2018.20865","volume":"321","author":"E O\u2019Connor","year":"2019","unstructured":"O\u2019Connor E, Senger CA, Henninger ML, Coppola E, Gaynes BN. Interventions to prevent Perinatal Depression: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(6):588\u2013601.","journal-title":"JAMA"},{"issue":"4","key":"624_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/archdischild-2019-317433","volume":"105","author":"I Kleine","year":"2020","unstructured":"Kleine I. Interventions to prevent perinatal depression: US Preventive Services Task Force Recommendation Statement. Arch Dis Child Educ Pract Ed. 2020;105(4):242\u20133.","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"6","key":"624_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/jama.2019.0007","volume":"321","author":"USPST Force","year":"2019","unstructured":"Force USPST, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Interventions to prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(6):580\u20137.","journal-title":"JAMA"},{"issue":"4","key":"624_CR39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1080\/15374410802359726","volume":"37","author":"CE Foster","year":"2008","unstructured":"Foster CE, Webster MC, Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, et al. Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms. J Clin Child Adolesc Psychol. 2008;37(4):714\u201324.","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"12","key":"624_CR40","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1001\/jama.295.12.1389","volume":"295","author":"MM Weissman","year":"2006","unstructured":"Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA. 2006;295(12):1389\u201398.","journal-title":"JAMA"},{"issue":"1","key":"624_CR41","first-page":"103","volume":"14","author":"MM Weissman","year":"2016","unstructured":"Weissman MM, Wickramaratne P, Pilowsky DJ, Poh E, Batten LA, Hernandez M, et al. Treatment of maternal depression in a Medication Clinical Trial and its effect on children. Focus (Am Psychiatr Publ). 2016;14(1):103\u201312.","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"624_CR42","doi-asserted-by":"crossref","unstructured":"Mojtabai R, Olfson M, Han B. National Trends in the prevalence and treatment of Depression in Adolescents and Young adults. Pediatrics. 2016;138(6).","DOI":"10.1542\/peds.2016-1878"},{"issue":"9","key":"624_CR43","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1176\/ajp.2006.163.9.1554","volume":"163","author":"FM Mondimore","year":"2006","unstructured":"Mondimore FM, Zandi PP, Mackinnon DF, McInnis MG, Miller EB, Crowe RP, et al. Familial aggregation of illness chronicity in recurrent, early-onset major depression pedigrees. Am J Psychiatry. 2006;163(9):1554\u201360.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"624_CR44","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jamainternmed.2022.4268","volume":"182","author":"EA Suarez","year":"2022","unstructured":"Suarez EA, Bateman BT, Hernandez-Diaz S, Straub L, Wisner KL, Gray KJ, et al. Association of antidepressant use during pregnancy with risk of Neurodevelopmental Disorders in Children. JAMA Intern Med. 2022;182(11):1149\u201360.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"624_CR45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bph.15319","volume":"178","author":"A Puscian","year":"2021","unstructured":"Puscian A, Winiarski M, Leski S, Charzewski L, Nikolaev T, Borowska J, et al. Chronic fluoxetine treatment impairs motivation and reward learning by affecting neuronal plasticity in the central amygdala. Br J Pharmacol. 2021;178(3):672\u201388.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"624_CR46","doi-asserted-by":"publisher","first-page":"e22125","DOI":"10.1002\/dev.22125","volume":"63","author":"KSJ Campbell","year":"2021","unstructured":"Campbell KSJ, Williams LJ, Bjornson BH, Weik E, Brain U, Grunau RE, et al. Prenatal antidepressant exposure and sex differences in neonatal corpus callosum microstructure. Dev Psychobiol. 2021;63(6):e22125.","journal-title":"Dev Psychobiol"},{"issue":"6","key":"624_CR47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamapediatrics.2017.5227","volume":"172","author":"C Lugo-Candelas","year":"2018","unstructured":"Lugo-Candelas C, Cha J, Hong S, Bastidas V, Weissman M, Fifer WP, et al. Associations between Brain structure and connectivity in infants and exposure to selective serotonin reuptake inhibitors during pregnancy. JAMA Pediatr. 2018;172(6):525\u201333.","journal-title":"JAMA Pediatr"}],"container-title":["Child and Adolescent Psychiatry and Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13034-023-00624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13034-023-00624-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13034-023-00624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T15:06:28Z","timestamp":1686927988000},"score":1,"resource":{"primary":{"URL":"https:\/\/capmh.biomedcentral.com\/articles\/10.1186\/s13034-023-00624-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s13034-023-00624-9","relation":{},"ISSN":["1753-2000"],"issn-type":[{"value":"1753-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional data protection board at the University of Southern Denmark, the Danish Health Data Authority, and the DNBC approved the research project. As per Danish law, studies based entirely on registry data do not require approval from an ethics review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Weissman has received funding from the National Institute of Mental Health, the National Institute on Drug Abuse, the Brain and Behavior Research Foundation, the Sackler Foundation, the Templeton Foundation, and the Interstitial Cystitis association, and receives royalties from the Oxford University Press, Perseus Press, the American Psychiatric Association Press, and MultiHealth Systems. None of these present a conflict of interest. Dr. Potteg\u00e5rd reports participation in research projects funded by Alcon, Almirall, Astellas, AstraZeneca, Boehringer-Ingelheim, Novo Nordisk, Servier and LEO Pharma, all regulator-mandated phase IV-studies, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the work reported in this paper. Drs. Bliddal, Ernst, Gingrich, Strandberg-Larsen, Talati, and Wesselhoeft report no disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}